Leader
PAF, a potent proinflammatory mediator, looking for its role in the pathogenesis of joint damage
| The first 150 words of the full text of this article appear below. |
| |
Introduction |
|---|
Cell activation is accompanied by remodelling of its membrane components producing structurally diverse intracellular and extracellular lipids that seem to be essential in signal transduction, cell-cell communication, and as mediators in inflammation and pathophysiological mechanisms.1 Phospholipases are pivotal enzymes in the generation of these lipids, including eicosanoids (mostly prostaglandins), platelet activating factor (PAF), diacylglycerides, and other newly discovered bioactive autacoids.
PAF is a potent proinflammatory phospholipid mediator, involved in the pathogenesis of lung, liver, cardiovascular, renal, and other diseases.2 The gene coding for the human specific PAF receptor has recently been cloned from leucocytes showing homology to G protein coupled receptors.3
During the inflammatory arthritic process there are basically tissue
damage phenomena combined with reparative processes. In brief,
endothelial damage is followed by inflammatory cell infiltration in the
perivascular area and synovial membrane. Furthermore, hyperplasia of
synovial cells and accumulation of fibronectin and other matrix
proteins are also seen. These
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
